The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

Shares of Omeros touched a 52-week high, a day after the company said it could resubmit its biologics license application for narsoplimab to the Food and Drug Administration. In Thursday afternoon ...

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...

The patient had been suffering from hard-to-control diabetes despite intensive insulin treatment and had received a pancreas ...

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

As described in previous updates, we have been working closely with FDA regarding the anticipated resubmission of our Biologics License Application, or BLA for narsoplimab in hematopoietic stem cell ...